Rubin Jami 4
4 · Relay Therapeutics, Inc. · Filed Jun 12, 2024
Insider Transaction Report
Form 4
Rubin Jami
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-06-10−42,242→ 0 totalExercise: $5.04Exp: 2029-10-09→ Common Stock (42,242 underlying) - Exercise/Conversion
Common Stock
2024-06-10$5.04/sh+42,242$212,900→ 67,242 total
Footnotes (2)
- [F1]This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
- [F2]This stock option vested in sixteen (16) equal quarterly installments following the vesting commencement date of October 10, 2019, subject to the reporting person's continued service relationship through each vesting date.